👀 The latest issue of Diabetes, Obesity, and CardioMetabolic CARE (DOCM CARE), the new ADA journal focused on comprehensive, person-centered care, is live.
🔗 https://t.co/FUf88J8sCh
Featuring:
✨ The Cost of Inaction in Treating Obesity
✨ Clinic for Athletes With T1D
✨ & more!
@AmDiabetesAssn@ADA_DiabetesPro
#Diabetes #Obesity #CardiometabolicHealth
HISTORY
Frederick Banting and Charles Best tested insulin by injecting themselves with it first to see if it was safe for human trials, which caused them to experience weakness and dizziness, signs of hypoglycemia.
Source: Diabetes Australia
#T1D#history
The Dexcom CGM recall announced today only affects people who use a Dexcom reader. If you use a phone app to monitor your readings, your CGM will work normally.
Here is the latest statement from Dexcom:
In rare circumstances, certain Dexcom CGM receivers may experience issues with audio alerts and alarms due to the speaker not functioning as intended. This recall does not impact users who use Dexcom mobile apps as the display device for their glucose values, alerts and alarms, which constitutes a majority of our users globally. For the affected receivers which have been distributed, the reported incidence rate is 0.015%.
We are actively working with local regulatory agencies, and on 12th May began notifying users that may be impacted to check if their device is affected. If the user has an affected device, Dexcom will provide a no-cost replacement. Customers can check if their receiver is impacted at https://t.co/ishMmcyNZk
📢 Call for Papers: Submissions open July 1, 2025, for DOC CARE®, ADA’s new journal for diabetes, obesity & cardiometabolic care. 📷https://t.co/TssQCOVUSb #DOCCARE#CallForPapers#DiabetesCare#ADA_Pubs
⭐️Best of #DiabetesCareADA2024⭐️ | #02 ALTMETRIC
Disparities in Acute and Chronic Complications of Diabetes Along the U.S. Rural-Urban Continuum
-Kyle Steiger et al.
https://t.co/t3R6waJ1dL
@ADA_Pubs
Original Article: Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis (ESSENCE trial) https://t.co/8zxann2S8C
#Endocrinology#Gastroenterology
Researchers have developed a simpler way to predict type 1 diabetes to accelerate development of prevention therapies and monitor their effectiveness. @ADA_Pubs
Read Here➡️ https://t.co/kld2rGvuR3
1/ 🚨 NEW #5Pearls: Lp(a) and ASCVD Risk
Lp(a) is a lipoprotein similar to LDL but a different entity!
Lp(a) has important implications for cardiovascular disease ‼️
🖥️: https://t.co/16POEATPCC
Sponsor: Freed AI
The 2025 Abridged Standards of Care is now available online! Designed specifically for primary care providers, this essential resource is available in a user-friendly infographic format.
Download it today: https://t.co/WnHPXt6Rq6
HISTORY
Sadie Gairns (1898-1986) studied under J.R.R. Macleod and received an M.A. in Physiology in 1922. She was hired as a research assistant to F.G. Banting, with whom she worked closely for the next 19 years. (Her name appears with his on 7 research papers). #T1D
Congratulations to the Ohio Health and OUHCOM Diabetology fellowship program on its recent achievement of full accreditation from the American College of Diabetology!
Parental type 2 diabetes is more common in children with type 1 diabetes. Children with type 1 diabetes and family history of type 2 diabetes had higher BMI and less often the high-risk HLA-genotype. @ADA_Pubs
Read Here➡️ https://t.co/qrwjWMEfNC